EffRx Pharmaceuticals: EffRx Obtains Swiss Marketing Authorization for Bronchitol in Cystic Fibrosis
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol (inhaled mannitol)
United States New South Wales Kostenloser Wertpapierhandel Pamela Saredi Effrx Pharmaceuticals Pharmaxis Ltd
Source: finanznachrichten.de